key: cord-350166-loxe11d6
authors: Garmendia, Onintza; Rodríguez-Lazaro, Miguel A.; Otero, Jorge; Phan, Phuong; Stoyanova, Alexandrina; Dinh-Xuan, Anh Tuan; Gozal, David; Navajas, Daniel; Montserrat, Josep M.; Farré, Ramon
title: Low-cost, easy-to-build non-invasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing
date: 2020-04-20
journal: Eur Respir J
DOI: 10.1183/13993003.00846-2020
sha: 
doc_id: 350166
cord_uid: loxe11d6

AIM: Current pricing of commercial mechanical ventilators in low/middle-income countries (LMICs) markedly restricts their availability, and consequently a considerable number of patients with acute/chronic respiratory failure cannot be adequately treated. Our aim was to design and test an affordable and easy-to-build non-invasive bilevel pressure ventilator to allow reducing the serious shortage of ventilators in LMICs. METHODS: The ventilator was built using off-the-shelf materials available via e-commerce and was based on a high-pressure blower, two pressure transducers and an Arduino Nano controller with a digital display (total retail cost <75 US$), with construction details open source provided for free replication. The ventilator was evaluated (and compared with a commercially available device (Lumis-150, Resmed): a) in the bench using an actively breathing patient simulator mimicking a range of obstructive/restrictive disease and b) in 12 healthy volunteers wearing a high airway resistance and thoracic/abdominal bands to mimic obstructive/restrictive patients. RESULTS: The designed ventilator provided inspiratory/expiratory pressures up to 20/10 cmH(2)O, respectively, with no faulty triggering or cycling both in the bench test and in volunteers. Breathing difficulty score rated (1–10 scale) by the loaded breathing subjects was significantly (p<0.005) decreased from 5.45±1.68 without support to 2.83±1.66 when using the prototype ventilator, which showed no difference with the commercial device (2.80±1.48; p=1.000). CONCLUSION: The low-cost, easy-to-build non-invasive ventilator performs similarly as a high-quality commercial device, with its open-source hardware description, will allow for free replication and use in LMICs, facilitating application of this life-saving therapy to patients who otherwise could not be treated.

Non-invasive mechanical ventilation (NIV) is a widely used and accepted treatment for chronic respiratory diseases and, in some cases, it is also an alternative to invasive ventilation options for patients with acute respiratory failure caused by a variety of aetiologies (1) . Although positive pressure ventilation in low-and middleincome countries (LMIC) is most frequently provided invasively, the benefits of NIV are being increasingly recognised. Indeed, for obvious reasons of cost and ease of use, NIV appears to be not only an effective, but also a particularly suitable approach to provide respiratory support in patients living in developing low-income economies (2) . This is especially relevant since in these regions the burden of critical illness is large, and is expected to increase with growing urbanization, emerging epidemics and expanding access to hospitals (2) . Furthermore, the elevated cost of healthcare staffing, infrastructure needs, and onerous access to supplies have hampered the development of fully equipped intensive care units (ICU) in LMICs (3) . As a consequence, the demand for cost-effective medical equipment, such as mechanical ventilators, is likely to greatly increase in those countries. Moreover, mechanical ventilators are costly, which markedly restricts their availability, and consequently the ability to adequately treat a significant number of patients with both acute and chronic respiratory failure in LMICs.

These issues are all the more evident in light of the ongoing corona virus pandemic, where even industrialized economies are encountering significant shortages in the number of available ventilators to meet the demands imposed by this disease, such that availability of non-invasive respiratory support may be valuable for certain patients or as a temporary bridge (4, 5) .

Philanthropic donation of medical devices may help in providing mechanical ventilators to un-resourced regions in LMICs, but these initiatives are fraught with considerable limitations. Indeed, donation of commercially available equipment is expensive and is only partially effective since it has been reported that up to 50% of donated devices become unusable due to lack of adequate maintenance and inability to obtain spare parts (6) . In addition, donations are hardly sustainable because they require long-term commitments such as to provide device servicing. In this context, alternative solutions that are based on in-house manufacturing of pressure support devices (7, 8) could reduce the serious shortage of ventilators in LMICs. Accordingly, the aim of this study was to design and test a novel low-cost bilevel pressure support ventilator, and provide open access to the detailed technical information, thereby allowing for free and unrestricted replication and implementation. To ascertain adequate performance of the device, bench testing was carried out based on simulated patients with obstructive/restrictive diseases under well-controlled conditions, a common widely accepted approach to test therapeutic devices for respiratory support (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Then, and following the existent literature (19) (20) (21) , the prototype ventilator was tested in healthy volunteers subjected to obstructive-restrictive loaded breathing to mimic patients with respiratory diseases requiring NIV.

The ventilator was designed to be affordable and easy-to-build, providing an open-source hardware description to allow free replication. The prototype was built using off-the-shelf materials available via e-commerce: a high-pressure blower and its driver (WM7040, Ning Bo Feng Hua Wei Cheng Motor Factory, Zhejiang, China), two pressure transducers (XGZP6847005KPG, CFSensor, Wuhu, Anhui, China) and an Arduino Nano controller with a digital display. Pressure and flow were continuously measured at the outlet of the ventilator and fed into the controller which was provided with a custom-made code to detect inspirations and expirations and to accordingly trigger the inspiratory and expiratory pressures generated by the blower. The ventilator can operate in timed or spontaneous timed (ST) mode (spontaneous breaths of patients are assisted and if the patient's effort is not detected a timed breath is triggered according to a rescue frequency). The retail cost of this ventilator prototype was below 75 US$, and includes all required electronic circuits and power source. Noteworthy, this cost could be considerably reduced by wholesale purchasing. All the technical information and detailed circuit schematics and controller code required to build this ventilator (including optional enclosure by conventional 3D printer) is available for release under free terms following the open-source hardware approach in the online supplement (Technical_Description.zip) . Figure 1 shows external and internal images of the prototype.

To assess the performance of the novel bilevel pressure ventilator under wellcontrolled conditions, the prototype was evaluated in a bench test using an active patient simulator modelling the respiratory mechanics of patients with different levels of obstructive/restrictive diseases ( Figure 2 ). The passive component of the respiratory system model was a variable resistance-compliance (R-C) lung model (Adult SmartLung, IMT Analytics, Switzerland). To implement an active breathing model, the passive R-C system simulating the lungs was enclosed in a cylindrical box connected to a negative pressure source (Figure 2 ), as explained in detail in the online supplement (Supplementary_Methods&Results.pdf). Figure 3 shows examples of the simulated pleural pressures applied to the passive model to implement active patient models, which combined 2 breathing frequencies (15 and 20 breaths/min) and 3 negative peak pressure amplitudes (-6, -9, -12 cm H 2 O). Four respiratory R-C systems were set for testing the ventilator, mimicking a patient with mild disease, a purely obstructive patient (increased R), a purely restrictive patient (reduced compliance) and a patient with both obstruction and restriction (Table 1) . Two breathing frequencies were used and different inspiratory efforts were set according to the level of disease ( Table 1 ). As shown in 

The ventilator prototype was tested in 12 healthy volunteers (5 of them women) recruited from the university environment. Their mean age was 32.4±5.8 years and their body mass index was 23.3±2.0 kg/m 2 (mean±SE). To mimic the respiratory load corresponding to a patient requiring NIV the volunteers were instrumented to increase their airway resistance and to decrease their respiratory compliance, as explained in detail in the online supplement (Supplementary_Methods&Results.pdf). The protocol was carried out by one respiratory physiotherapist expert in NIV. The volunteer subject was sitting in a comfortable armchair and was equipped with a finger pulse oximeter for monitoring oxygen saturation (WristOx 2 , Model 3150, Nonin Medical, Plymouth). First, he/she was allowed to get familiar with the use of a nasal mask and NIV for 3 minutes.

To this end, he/she was connected to a non-invasive ventilator (Lumis 150, VPAP ST, Resmed) through conventional nasal mask and tubing, with inspiratory and expiratory pressures set to 8 and 4 cmH 2 O, respectively. Subsequently, the subject was equipped with the resistive and restrictive loads and breathed spontaneously (unsupported) for 2 min. After that period of loaded breathing, the volunteer was asked to score his/her breathing discomfort sensation on a visual analog scale where 1 would correspond to spontaneous normal breathing and 10 to the maximum breathing discomfort he/she could consider unbearable. Then, he/she was connected to a mechanical ventilator with inspiratory and expiratory pressures set to 16 and 6 cmH 2 O, respectively, in spontaneous trigger (ST) mode with a backup frequency of 12 breaths/min. This ventilator was either the prototype under test or a commercially available highperformance device (Lumis 150, VPAP ST, Resmed; default settings), determined at random. At the end of a 2 min period, the subject was again asked to score his/her breathing discomfort and, without interruption nor notice to the subject, the ventilator was shifted to the other device for 2 min and then the volunteer was asked again for scoring discomfort. This process of alternating the ventilator (prototype or commercial) was repeated twice more. The discomfort scoring finally assigned to each ventilator was the mean score of the 3 periods corresponding to each device. Any faulty triggering or cycling, as observed through inspection of the real time nasal pressure signal and subject's breathing activity, was registered by the physiotherapist.

In the bench test, the different investigated variables were assessed by comparing the data obtained with the prototype and the commercial ventilator by means of a paired t-test. In the test with voluntary subjects, discomfort scores when the individual was not mechanically supported and when supported by the two ventilators were compared by paired t-test for normally distributed variables and by Wilcoxon signed rank test for non-normally distributed variables. A value of p<0.05 was considered statistically significant. 

Testing in volunteers with resistive and restrictive loads provided positive results on the feasibility of the ventilator prototype for application in humans. As expected from healthy subjects, no decrease in oxygen saturation was observed throughout the whole test period when compared with the unsupported baseline (97.0±1.3%):

96.8±1.0% (p=0.51) and 96.8±0.9% (p=0.23) when supported with the prototype and commercial ventilator, respectively. As shown in Figure 6 , discomfort scoring when the 12 subjects were subjected to respiratory loading was 5.45±1.68. These values significantly decreased to 2.83±1.66 (p<0.005) when the loaded patient's breathing was supported by the prototype ventilator. Interestingly, the relief in breathing difficulty was virtually the same as the one achieved with the high-performance commercial ventilator (2.80±1.48; p=1.000). No significant differences were observed in the variability across the 3 measurements of breathing discomfort (p=0.208; average standard deviation of 0.61). Figure 7 presents an example of the nasal pressure and flow signals when the prototype ventilator, set to considerable values of NIV inspiratory and expiratory pressures, was applied to a loaded-breathing volunteer, illustrating that the pressure waveform was suitable, and that the ventilator smoothly followed the breathing pattern of the subjects since no faulty triggering of cycling was detected. Figure 2 .Suppl (in the Supplementary_-Methods&Results.pdf) shows that the prototype ventilator was able to trigger mandatory ventilation cycles in case of absence of subject's inspiratory effort.

Here we describe a very low cost bilevel pressure support ventilator which is Furthermore, the ventilator control can be adapted to take into account the pressure drop induced by a humidifier in case this component is connected between the ventilator output and the tube connecting to the patient's mask. Noteworthy, the proposed approach for ventilator construction empowers the final users in LMICs to fully control the procedure, to adapt it to the local conditions, and to update the used components in response to market availability. Moreover, continued support from and collaboration with experienced teams abroad is easy and readily feasible. In a time when the most complex devices appear to be needed and can only be provided by a very competitive and specialized industry, the simplicity and performance of this designed low cost device reminds us of the need to go back to the basics, inasmuch as the rationale and implementation of NIV has not changed substantially from the pioneering times when this therapy was developed (24) .

The bench test was carried out using a commonly used type of actively breathing patient simulator (9) (10) (11) 16, 18) , mimicking a wide spectrum of patient's respiratory mechanical alterations (obstruction and/or restriction), and including normal and high breathing frequencies. Moreover, the ventilator was tested under conditions reproducing an unintended leak, a circumstance frequently encountered during clinical NIV practice.

The 16 different bench test settings (Table 1) used to test the ventilator covered the wide range of conditions that non-invasive ventilators are exposed to in real-life clinical applications. The bench test showed that, regardless of the stressing test conditions, the prototype ventilator provided the target bilevel pressures (Figure 5 .A) with no faulty triggering or cycling, and with a suitable triggering delay ( Figure 5 .B), thereby enabling good synchronization with the inspiratory effort of the simulated patient. The relative simplicity of the feedback control system in the prototype ventilator explains the slightly different shape of pressure waveform observed over the wide range of test conditions ( Figure 5 .A), and also facilitates interpretation of the determinants of the small increases in peak inspiratory pressures. Whereas the commercial device applied an almost square pressure signal, the pressure waveform generated by the prototype exhibited progressive increase and decrease in inspiratory pressures (Figure 4 ). This is consistent with the fact that the commercial device used as a comparator was probably equipped with a more powerful (and hence expensive) feedback system to control its blower. However, several other commercially available ventilators exhibit patterns of inspiratory pressures similar to those observed in the prototype (Figure 4 .A) (24) . In fact, the slope of the ramp of increasing inspiratory pressure is one of the parameters that can be set by the user in some commercially available devices, since excessively rapid increases in early onset of inspiratory pressures may lead to patient discomfort ( Figure 4 .B) by not mimicking the physiological inspiratory patterns characterized by progressive increases in flow. Although tidal volume was not a direct outcome variable controlled by pressure support ventilators, it is interesting to note that the prototype ventilator resulted in tidal volumes that were similar to the ones generated by the commercial device ( Figure 5.B) , adding further support to the suitability of the prototype ventilator for generating inspiratory pressure waveforms and adequate tidal volumes in a wide spectrum of simulated patients ( Table 1 ).

The applicability pilot study was carried out in healthy volunteers subjected to obstructive and restrictive breathing loads. This model is widely used in the literature to simulate the mechanical load of the respiratory system for investigating ventilation (19) (20) (21) and for simulating dyspnoea (26, 27) . In fact, the level of obstruction-restriction we applied to our volunteers resulted in a breathing discomfort score (Figure 7 ) similar to the ones set in recent reports to mimic dyspnoea by loaded breathing (26, 27) . The results obtained when testing the applicability of the prototype ventilator in humans showed that, similar to the bench test, there were no faulty triggering or cycling events, that the pressure waveform was similar to those typically observed in commercial ventilators (Figures 7 and 2.Suppl) , and that the relief of breathing discomfort was virtually the same as the one achieved by the commercial ventilator ( Figure 6 ).

In addition to methodological and technical issues discussed above, the work presented here requires that we specifically address two aspects that are usually lacking in medical device studies: a) industrial/commercial model and b) safety/ethical issues.

Indeed, in this work we propose an alternative procedure for building ventilators inhouse and locally, i.e., outside the conventional medical device industrial market. There is little doubt that industry-based conventional production chains, including design, manufacturing and commercialization, play a key role in the healthcare system. Accordingly, industry heavily invests in R&D and translates new knowledge from the laboratory bench to patient bedside. In other words, the medical device industry searches and delivers life-enhancing innovative solutions. Unfortunately, such industrially-based model is hardly suitable to low-income settings that are usually resource scarce, and where the provision of even adequate basic services to the population is challenging. The main reason why the conventional industrial model does not work in LMICs is that the standard industrial production scheme, which also applies to entirely non-for-profit companies, entails significant costs beyond those strictly required for device manufacturing.

The vast majority of medical device companies are small and medium-sized, employing less than 50 people, both in Europe (95% of all medical technology firms) and in the USA (80%) (28) . Moreover, those companies, mainly based in USA and Canada (49% of the world market), Europe (27%), Japan (7%) and China (6%), are highly and globally regulated to guarantee the safety and performance of their innovative and high technology products throughout their life-cycle, as well as pre-and post-marketing (28) . Unlike many other industries, R&D expenditures represent a significant cost component for medical device companies. These companies spend on average between 6% and 12% of revenues towards R&D investment (29) , with some niche firms or start-ups incurring even higher R&D costs (> 20%). Average selling, general and administrative expenses (SG&A), which include marketing, advertising and promotion costs and general and administrative costs, account for about one-third of total revenues (30) . Importantly, the cost of goods sold (COGS), which measures the total cost that it takes for a medical device company to manufacture its products including labour, material costs, rental and utility costs, represent between 35% and 40% of revenues (30) , with the remaining costs going to taxes, interests and depreciation. Thus, a disproportionately large share of medical device companies' revenues is slated for expenses beyond those needed to manufacture their products. In contrast, in the approach we describe in this work, as ventilator assembly is performed locally or directly linked local technical partners, the only costs incurred are those associated with purchasing of the components and the actual labor costs of assembling the device, both of which are low thanks to e-commerce and labor costs in LMICs, respectively. Noteworthy, the approach proposed here may not only allow for adequate availability of ventilators to patients (31) (32) (33) (34) , but may also contribute to the development of the local industry network in LMICs (35) (36) (37) .

Regarding safety and ethical issues, it is important to emphasize that the development and testing of the NIV devices that are available in market nowadays, was made possible by development of devices built in-house by physicians and researchers in developed countries, and that these innovations were designed, tested and improved in patients before the corresponding labeling was obtained (24) . Notwithstanding, the in-house ventilator proposed here does not have the conventional FDA/CE approvals.

Obviously, such approval procedures are tremendously important for ensuring that medical devices placed into the market are safe and reliable and, as such, have contributed to the progress currently achieved in health care. However, obtaining FDA/CE labels is a process devised mainly for the industry in developed countries and is extremely expensive in terms of LMICs financial resources. Although these countries do not have the complex infrastructure required for such costly processes, simplified or ad-hoc approval procedures could be provided by local authorities or hospital Ethical Boards. However, particularly in light of the non-existent alternative of using industrial ventilators, i.e., leaving the patient untreated with the attendant consequences. Under such difficult circumstances, the ethical trade-off towards compassionate use of medical devices, a mechanism already in place for non-labelled therapies in developed countries, may be considered.

In conclusion, we have designed a low-cost easy-assembly ventilator with excellent performance characteristics in both the bench and in voluntary subjects.

If as anticipated from these preliminary results, clinical field tests are favourable, this low-cost device may enable provision of respiratory support to patients in LMICs who otherwise would have no access to this potentially life saving therapy, as well as escalation of ventilatory support availability in strenuous circumstances such as those imposed by respiratory virus pandemics. Table 1 for conditions definition). 

To implement an active breathing model, the passive R-C system simulating the lungs was enclosed in a cylindrical box (20 cm diameter, 30 cm height), leaving the R-C inlet (airway opening) outside the box (Figure 2 ). The air in this box A half-cycle sinusoidal voltage signal driving the blower allowed to generate simulated pleural pressures realistically mimicking those induced by inspiratory muscles in terms of amplitude, frequency and time course.

The volunteers were naïve to the pathophysiology of respiratory diseases and had never received mechanical ventilation. They were provided with detailed explanations of the procedure in a specific meeting, and signed a written consent to participate in the protocol. Each volunteer was told, in lay language, that: a) his/her respiration would be partially hindered to simulate the breathing difficulty perceived during a heavy physical work or sport practice, b) that a device to facilitate his/her breathing would then be connected through a nasal mask and c) that he/she would be asked to score the level of comfort/discomfort experienced with/without the breathing support.

To mimic the respiratory load corresponding to an obstructive patient, a meshwire screen resistance (9.5 cmH 2 O/L/s) was placed at the inlet of a conventional nasal mask for non-invasive ventilation. The built-in intended leak of the mask was sealed, and a 5 mm orifice intended leak open to the room air was placed between the end of the flexible tube connecting the ventilator to the mask and the 9.5 cmH 2 O/L/s added resistance which hence played the role of an actual increase in patient's airway resistance. To also load the volunteer with a restrictive component, a nonflexible belt (9 cm width) was tightly fit around the abdomen and a spring-based flexible belt (9 cm width) was adjusted around the thorax at the level of the manubrium sterni. 

Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure

Non-invasive ventilation in children and adults in low-and low-middle income countries: A systematic review and meta-analysis

Intensive Care Unit Capacity in Low-Income Countries: A Systematic Review

The Toughest Triage -Allocating Ventilators in a Pandemic

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Beyond good intentions: lessons on equipment donation from an African hospital

Novel Approach for Providing Pediatric Continuous Positive Airway Pressure Devices in Low-Income, Underresourced Regions

Easy-to-build and affordable continuous positive airway pressure CPAP device for adult patients in low-income countries

Effect of Leak and Breathing Pattern on the Accuracy of Tidal Volume Estimation by Commercial Home Ventilators: A Bench Study. Respir Care

Patient-Ventilator Asynchrony During Noninvasive Ventilation

Bench studies evaluating devices for noninvasive ventilation: critical analysis and future perspectives

Response of Automatic Continuous Positive Airway Pressure Devices to Different Sleep Breathing Patterns

Bench Model To Simulate Upper Airway Obstruction for Analyzing Automatic Continuous Positive Airway Pressure Devices

Comparative assessment of several automatic CPAP devices' responses: a bench test study

Novel Approach to Simulate Sleep Apnea Patients for Evaluating Positive Pressure Therapy Devices

Technology for noninvasive mechanical ventilation: Looking into the black box

Mimicking a flow-limited human upper airway using a collapsible tube: relationships between flow patterns and pressures in a respiratory model

Performance Characteristics of Bilevel Pressure Ventilators

Chest wall strapping. An old physiology experiment with new relevance to small airways diseases

Respiratory comfort and breathing pattern during volume proportional assist ventilation and pressure support ventilation: A study on volunteers with artificially reduced compliance

Breathing pattern and perception at different levels of volume assist and pressure support in volunteers

Trigger performance of mid-level ICU mechanical ventilators during assisted ventilation: a bench study

Patient-Ventilator Interaction During Noninvasive Ventilation in Simulated COPD

Nasal Positive Airway Pressure and Sleep Apnea. Reflections on an Experimental Method That Became a Therapy

Performance characteristics of 10 home mechanical ventilators in pressure-support mode: a comparative bench study

When Breathing Interferes with Cognition: Experimental Inspiratory Loading Alters Timed Up-and-Go Test in Normal Humans

Interferences between breathing, experimental dyspnoea and bodily selfconsciousness

The European Medical Technology Industry -in figures

As change accelerates, how can medtechs move ahead and stay there? Pulse of the industry 2017

medtechs-move-ahead-and-stay-there/$FILE/ey-as-change-accelerates-how-canmedtechs-move-ahead-and-stay-there

The Business Case for Medical Device Quality

Quantifying the Value of Open Source Hardware Development

Maximizing Returns for Public Funding of Medical Research with Open-source Hardware

Open-source hardware for medical devices

Affordable medical technologies: bringing Value-Based Design into global health

Rethinking health sector procurement as developmental linkages in East Africa

Open source biomedical engineering for sustainability in African healthcare: combining academic excellence with innovation


